木薯科学报告了一项在公认的硬化综合症（OSC）相关癫痫小鼠模型中评价Simufilam的临床前结果，这是Simufilam治疗OSC相关癫痫的首项临床研究预计将于2026年下半年开始

The Tsc1-CKO mice were treated with several doses of simufilam. Seizure activity was monitored for approximately three weeks after onset, and simufilam was evaluated against treatment with vehicle alone. The data showed that simufilam attenuated the progression of seizure activity, with a statistically significant correlation between simufilam dose and the number of seizures by the end of the study. Not all parameters measured reached statistical significance. The Company intends to present data and analyses in an upcoming scientific conference and publication.